Shareholders Approve Expanded Equity Incentive Plan and Officer Exculpation
RYZ sits 48% above its 52-week low of $19.02.
Summary
Shareholders approved an increase of 1.5 million shares for the equity incentive plan, potentially diluting existing shareholders, and also voted to exculpate officers from certain liabilities. A director was not re-elected, and the say-on-pay vote passed despite significant opposition.
Key Events · Corporate Governance and Compliance · RYZ
-
Equity Incentive Plan Expanded
Shareholders approved an increase of 1,500,000 shares for the Third Amended and Restated 2014 Omnibus Incentive Plan, extending its term to April 29, 2036. This authorization for additional equity awards represents a substantial potential dilution.
-
Officer Exculpation Approved
Shareholders approved an amendment to the company's Amended and Restated Certificate of Incorporation to provide for the exculpation of certain officers in specific circumstances, reducing their personal liability.
-
Director Not Re-elected
Kirk K. Calhoun was not nominated for re-election to the Board of Directors and ceased to serve as a director effective April 30, 2026.
-
Say-on-Pay Vote Passed with Dissent
The advisory resolution approving executive compensation passed, but with 16.2 million votes against, indicating notable shareholder opposition.
Analysis · RYZ · Trade & Services
Shareholders approved a significant increase of 1.5 million shares for the company's omnibus incentive plan, extending its expiration date to 2036. This authorization for additional equity awards represents a notable potential dilution for existing shareholders. Additionally, shareholders approved an amendment to the company's charter to exculpate officers from certain liabilities, a governance change that may be viewed with caution by some investors. The advisory 'say-on-pay' vote also passed, but with a substantial percentage of votes cast against executive compensation, indicating some shareholder dissatisfaction. Kirk K. Calhoun was not re-elected to the Board of Directors.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 29.5% of the 2875 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RYZ was trading at $28.23 on NYSE in the Trade & Services sector, with a market capitalization of approximately $899.2M. The 52-week trading range was $19.02 to $30.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.